Katelijne van de Vooren1, Alessandro Curto, Livio Garattini. Show Affiliations » 1. Centre for Health Economics, Mario Negri Institute for Pharmacological Research, 24020 Ranica, BG, Italy.
Abstract
Mesh： See more » Antibodies, Monoclonal/economicsAntibodies, Monoclonal, Humanized/economicsAntineoplastic Agents/economicsBevacizumabCetuximabCost ControlCost-Benefit AnalysisDeductibles and CoinsuranceHealth Care CostsHumansNeoplasms/drug therapyNeoplasms/economicsPatient Participation
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBevacizumabCetuximab
Year: 2013 PMID： 23347986 DOI： 10.1136/bmj.f349
Source DB: PubMed Journal: BMJ ISSN： 0959-8138